ALBERTDAVD vs PGHL: Stock Comparison

Albert David Limited vs Procter & Gamble Health Limited

Live data: 22 July 2026, 2:54 PM IST • Source: NSE and company filings

Procter & Gamble Health Limited is the larger company by market capitalisation. Albert David Limited shows a lower P/E, while Procter & Gamble Health Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Albert David Limited and Procter & Gamble Health Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, ALBERTDAVD is more favourable on 2 of 13 scored metrics and PGHL on 11These counts are context-free and are not an overall rating.

Key Differences

Market Cap
PGHL is the larger company
₹11,172 Cr vs ₹391 Cr
P/E Ratio
ALBERTDAVD has a lower P/E
-264.18x vs 34.28x
P/B Ratio
ALBERTDAVD has a lower P/B
1.01x vs 21.36x
EPS
PGHL has higher earnings per share
₹196.64 vs ₹-2.65
Dividend Yield
PGHL has a higher dividend yield
2.34% vs 0.72%
Revenue Growth (TTM YoY)
PGHL has faster revenue growth
19.1% vs 14.6%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 0%
Qtr Sales Growth
PGHL has stronger quarterly sales growth
19.1% vs 14.6%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALBERTDAVDPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALBERTDAVDPGHL
Live Price₹689.85₹6,737
Day Change-0.93%-0.63%
Volume1,4404,521
52-Week High₹922.95₹6,975
52-Week Low₹579.9₹4,707
Distance from 52W High-25.26%-3.41%

Valuation

MetricALBERTDAVDPGHL
Market Cap₹391 Cr₹11,172 Cr
P/E Ratio-264.18x34.28x
P/B Ratio1.01x21.36x
EPS₹-2.65₹196.64
Book Value₹686.04₹316.01
Dividend Yield0.72%2.34%

Growth

MetricALBERTDAVDPGHL
Revenue Growth (TTM YoY)14.6%19.1%
EPS Growth (TTM YoY)0%54.6%
Qtr Sales Growth14.6%19.1%
Qtr Profit Growth-107%54.6%

Profitability & Leverage

MetricALBERTDAVDPGHL
ROE-0.38%61.6%
ROCE0.77%83.5%
Net Margin-0.45%23.22%
Operating Margin1.64%32.4%
Debt to Equity0.08x0.02x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricALBERTDAVDPGHL
Promoter Holding62.24%0%
FII Holding0.58% 0.02 pp6.33% 0.13 pp
DII Holding1.66%12.44% 1.23 pp
Public Holding35.52% 0.02 pp29.42% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Albert David Limited and Procter & Gamble Health Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.